A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2016
At a glance
- Drugs MT 8554 (Primary)
- Indications Neurological disorders
- Focus Adverse reactions
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 05 Jan 2016 According to ClinicaTrials.gov record, status changed from recruiting to completed.
- 15 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 May 2015 New trial record